Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT)

被引：0

作者：

Lorch, A.

Rick, O.

Hartmann, J. T.

Metzner, B.

Glasmacher, A.

Berdel, W.

Schirren, R.

Bokemeyer, C.

Beyer, J.

机构：

[1] Univ Klinikum Giessen & Marburg, Marburg, Germany

[2] Klin Reinhardshohe, Bad Wildungen, Germany

[3] Univ Klinikum Tuebingen, Tubingen, Germany

[4] Klinikum Oldenburg, Oldenburg, Germany

[5] Univ Klinikum Bonn, Bonn, Germany

[6] Univ Klinikum Muenster, Munster, Germany

[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[8] Urban Krankenhaus Berlin, Berlin, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5086

引用

页数：1

共 50 条

[1] Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
Beyer, J
Kramar, A
Mandanas, R
Linkesch, W
Greinix, A
Droz, JP
Pico, JL
Diehl, A
Bokemeyer, C
Schmoll, HJ
Nichols, CR
Einhorn, LH
Siegert, W
BONE MARROW TRANSPLANTATION, 1998, 22 : S10 - S10
[2] Significance of high-dose chemotherapy (HDCT) for male germ cell tumors
Lorch, A.
Beyer, J.
Bokemeyer, C.
ONKOLOGE, 2013, 19 (07): : 568 - 572
[3] Has toxicity in young patients with Germ Cell Tumor (GCT) treated with High-Dose Chemotherapy (HDCT) any impact on weight?
Giannotti, F
Civinelli, MC
Martelli, S
Amati, P
Peccenini, R
Zambianchi, H
Papiani, G
De Giorgi, L
Cavallaro, M
Rosti, G
Marangolo, M
BONE MARROW TRANSPLANTATION, 2001, 27 : S389 - S389
[4] Management of progressive brain metastases in patients (pts) with relapsed germ-cell tumor (GCT) treated with salvage high-dose chemotherapy (HDCT).
King, Jennifer
Abonour, Rafat
Hassoun, Rebecca
Althouse, Sandra K.
Salous, Tareq
Hanna, Nasser H.
Einhorn, Lawrence H.
Adra, Nabil
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[5] Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts).
Feldman, Darren Richard
Voss, Martin Henner
Jia, Xiaoyu
Van Alstine, Lindsay Joy
Patil, Sujata
Fischer, Patricia
Sheinfeld, Joel
Bosl, George J.
Motzer, Robert John
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[6] INFECTIONS IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY FOR GERM-CELL TUMORS
DAUGAARD, G
NIELSEN, H
BRUUN, B
HANSEN, F
GEERTSEN, P
SCHONHEYDER, H
EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) : 2220 - 2222
[7] High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
Beyer, J.
Hackenthal, M.
Lorch, A.
Neubauer, A.
Dieing, A.
Rick, O.
Hartmann, J. T.
Bokemeyer, C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[8] Impact of response to induction chemotherapy in patients with germ cell tumors (GCT) receiving salvage high-dose chemotherapy (HDCT): an EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study
Necchi, A.
Miceli, R.
Bregni, M.
Berger, L. A.
Oechsle, K.
Schumacher, K.
Bourhis, J. H.
Laszlo, D.
Flechon, A.
Arpaci, F.
Secondino, S.
Raggi, D.
Dreger, P.
Krueger, W.
Ringhoffer, M.
Unal, A.
Nagler, A.
Campos
Wahlin
Donnini, I.
Badoglio, M.
Martino, M.
Pedrazzoli, P.
Lanza, F.
BONE MARROW TRANSPLANTATION, 2015, 50 : S53 - S53
[9] Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[10] Stellenwert der Hochdosischemotherapie (HDCT) beim männlichen KeimzelltumorSignificance of high-dose chemotherapy (HDCT) for male germ cell tumors
A. Lorch
J. Beyer
C. Bokemeyer
Der Onkologe, 2013, 19 (7): : 568 - 572

← 1 2 3 4 5 →